Senior insider sale
Chief Commercial Officer at AGIOS PHARMACEUTICALS, INC. — senior position signals high conviction
$243.7K
8.67K shares
What this filing means
MILANOVA TSVETA plans to sell 8.67K shares of AGIOS PHARMACEUTICALS, INC. valued at approximately $243.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/2/2026ACC: 0001439222-26-000026
Officer· Chief Commercial Officer
Since Mar 2026
8.67K
Shares to sell
$243.7K
Approx. market value
2.87K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Vesting of Restricted Stock Units
Not Applicable
3/2/2026
2.87KTotal acquired2.87K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/2/2026 | Vesting of Restricted Stock Units Not Applicable | 2.87K | — |
| Total | 2.87K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
2.87K
Market value
$77.6K
1/5/2026
—Completed
Units to sell
2.93K
Market value
$79.4K
12/30/2025
Planned — Approximate Date
NasdaqPlanned
Units to sell
2.87K
Market value
$86.7K
3/2/2026
Total
Units
8.67K
Value
$243.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/5/2026 | 2.87K | $77.6K | — | Completed |
12/30/2025 | 2.93K | $79.4K | — | Completed |
| Planned — Approximate Date | ||||
3/2/2026 | 2.87K | $86.7K | Nasdaq | Planned |
| Total | 8.67K | $243.7K | ||